Genocea Biosciences Inc EBIT margin
Cos'è EBIT margin di Genocea Biosciences Inc?
EBIT margin di Genocea Biosciences Inc è -1,902.09%
Qual è la definizione di EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin di aziende nel Health Care settore su NASDAQ rispetto a Genocea Biosciences Inc
Cosa fa Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Aziende con ebit margin simili a Genocea Biosciences Inc
- Field Trip Health ha EBIT margin di -1,986.17%
- Birla Tyres ha EBIT margin di -1,964.48%
- Adamis Pharmaceuticals ha EBIT margin di -1,957.91%
- Oncternal Therapeutics ha EBIT margin di -1,948.70%
- Serve Robotics Inc ha EBIT margin di -1,938.49%
- AC Immune SA ha EBIT margin di -1,923.84%
- Genocea Biosciences Inc ha EBIT margin di -1,902.09%
- Mirati Therapeutics Inc ha EBIT margin di -1,899.99%
- Cyclo Therapeutics ha EBIT margin di -1,831.29%
- Playgon Games ha EBIT margin di -1,811.96%
- ERYTECH Pharma S.A ha EBIT margin di -1,809.54%
- Celldex Therapeutics ha EBIT margin di -1,809.40%
- Zoetic International Plc ha EBIT margin di -1,802.73%